CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Cepexin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

28 API Suppliers, 20 USDMF, 5 JDMF, 1 EU WC, 5 NDC API, 3 Listed Suppliers

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers, 97 FDA Orange Book, 19 Europe, 6 Canada, 2 South Africa, 61 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 6 SPI Pharma, 1 Pharm-RX Chemical, 4 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 3 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 9 BASF, 2 CD Formulation, 1 Clariant, 7 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 1 Gloria Interchem, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 16 Kerry, 4 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 23 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 29 Direct Compression, 29 Thickeners and Stabilizers, 24 Granulation, 24 Disintegrants & Superdisintegrants, 18 Solubilizers, 16 Lubricants & Glidants, 14 Taste Masking, 14 Coating Systems & Additives, 12 Parenteral, 12 Co-Processed Excipients, 11 Topical, 10 Film Formers & Plasticizers, 8 Empty Capsules, 7 Rheology Modifiers, 7 Emulsifying Agents, 7 Controlled & Modified Release, 7 Chewable & Orodispersible Aids, 5 Surfactant & Foaming Agents, 5 API Stability Enhancers

DIGITAL CONTENT

111 News #PharmaBuzz

111 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 10 Regulatory FDF Prices

MARKET PLACE

14 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

12 Others

12 Others

Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
31/03/2026	ACS DOBFAR SPA	Italy	ACS Dobfar S.p.A	52946-0906	Cephalexin Monohydrate	2009-12-09	2026-12-31	BULK INGREDIENT	POWDER (1kg/kg)
31/03/2026	Aurobindo Pharma Limited	India	Aurobindo Pharma Limited	65862-338	Cephalexin	2024-01-05	2026-12-31	BULK INGREDIENT	POWDER (50kg/50kg)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Cepexin

Cepexin

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

28 API Suppliers

20 USDMF

5 JDMF

1 EU WC

5 NDC API

3 Listed Suppliers

DEVELOPMENTS

14 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers

97 FDA Orange Book

19 Europe

6 Canada

2 South Africa

61 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

6 SPI Pharma

1 Pharm-RX Chemical

4 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Kirsch Pharma

3 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

6 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

9 BASF

2 CD Formulation

1 Clariant

7 DFE Pharma

2 Finar

9 Gangwal Chemicals

1 Gloria Interchem

1 Ideal Cures

4 Ingredion Pharma Solutions

16 Kerry

4 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

13 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Pharmatrans-Sanaq

5 Pluviaendo

4 Prachin Chemical

1 Qualicaps

23 Roquette

8 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

4 Silverline Chemicals

1 The Dow Chemical Company

1 Valens Pharmachem

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders

29 Direct Compression

29 Thickeners and Stabilizers

24 Granulation

24 Disintegrants & Superdisintegrants

18 Solubilizers

16 Lubricants & Glidants

14 Taste Masking

CAPSULE;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 333MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 500MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 750MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons